STI571 Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia

Clinical trial NCT00015834 · COMPLETED

Trial details

NCT number: NCT00015834
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Blastic Phase Chronic Myelogenous Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Relapsing Chronic Myelogenous Leukemia

Start date: 2001-05-01
Primary completion: 2003-04-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.